Prestige Brands Holdings, Inc.  

(Public, NYSE:PBH)   Watch this stock  
Find more results for PBH
+1.64 (3.22%)
After Hours: 52.54 +0.01 (0.02%)
Dec 1, 4:42PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 50.75 - 53.06
52 week 31.89 - 54.25
Open 51.14
Vol / Avg. 619,361.00/307,986.00
Mkt cap 2.86B
P/E 26.99
Div/yield     -
EPS 1.95
Shares 52.75M
Beta 1.55
Inst. own 103%
Feb 3, 2016
Q3 2016 Prestige Brands Holdings Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 23, 2015
Prestige Brands Announces Conferencec call To Discuss Definitive Agreement to Acquire DenTek Holdings Inc - Webcast
Nov 18, 2015
Prestige Brands Holdings Inc at Morgan Stanley Global Consumer & Retail Conference
Nov 11, 2015
Prestige Brands Holdings Inc at Raymond James Boston Fall Investors Conference
Nov 5, 2015
Q2 2016 Prestige Brands Holdings Inc Earnings Release
Nov 5, 2015
Q2 2016 Prestige Brands Holdings Inc Earnings Call - Webcast
Sep 29, 2015
Prestige Brands Holdings Inc at Deutsche Bank Leveraged Finance Conference
Sep 17, 2015
Prestige Brands Holdings Inc at Credit Suisse Small & Mid Cap Conference
Sep 16, 2015
Prestige Brands Holdings Inc at B. Riley & Co Retail & Consumer Conference
Sep 8, 2015
Prestige Brands Holdings Inc at Barclays Global Consumer Staples Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin 15.43% 10.95%
Operating margin 33.92% 29.04%
EBITD margin - 31.76%
Return on average assets 4.85% 3.53%
Return on average equity 18.92% 13.14%
Employees 187 -
CDP Score - -


660 White Plains Rd
TARRYTOWN, NY 10591-5139
United States - Map
+1-914-5246800 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Prestige Brands Holdings, Inc. (Prestige) is a holding company. The Company is engaged in the marketing, sales and distribution of brand name, over-the-counter (OTC) healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, and club, convenience, and dollar stores in North America (the United States and Canada), and in Australia and certain other international markets. The Company operates through three segments: North American OTC Healthcare, International OTC Healthcare and Household Cleaning. The Company's major brands include Chloraseptic, Clear Eyes, Compound W, Dramamine, Efferdent, Little Remedies, Luden's, The Doctor's NightGuard, The Doctor's Brushpicks, BC/Goody's, Beano, Debrox, Gaviscon, Dermoplast, New-Skin, Fiber Choice, Ecotrin, Fess, Hydralyte, Monistat, e.p.t, Nix, Chore Boy, Comet and Spic and Span. The Company distributes across major retail channels, including mass merchandisers, food, drug, dollar, convenience and club stores.

Officers and directors

Ronald M. Lombardi CPA President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
David S. Marberger Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Timothy J. Connors Executive Vice President - Sales and Marketing
Age: 48
Bio & Compensation  - Reuters
Jean A. Boyko Ph.D. Senior Vice President - Science and Technology
Age: 59
Bio & Compensation  - Reuters
John F. Parkinson Senior Vice President - International
Age: 62
Bio & Compensation  - Reuters
Thomas Hochuli Vice President - Operations
Age: 50
Bio & Compensation  - Reuters
Paul Migaki Vice President - Strategic Planning, Canada and and Women’s Health
Age: 61
Bio & Compensation  - Reuters
Samuel C. Cowley Vice President - Business Development, General Counsel, Secretary
Age: 55
Bio & Compensation  - Reuters
Gary E. Costley Ph.D. Lead Independent Director
Age: 71
Bio & Compensation  - Reuters
John E. Byom Independent Director
Age: 61
Bio & Compensation  - Reuters